183 related articles for article (PubMed ID: 29752477)
21. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.
Tsutani Y; Miyata Y; Mimae T; Kushitani K; Takeshima Y; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Sep; 146(3):580-5. PubMed ID: 23778085
[TBL] [Abstract][Full Text] [Related]
22. Differences of tumor microenvironment between stage I lepidic-positive and lepidic-negative lung adenocarcinomas.
Katsumata S; Aokage K; Miyoshi T; Tane K; Nakamura H; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Hayashi R; Tsuboi M; Ishii G
J Thorac Cardiovasc Surg; 2018 Oct; 156(4):1679-1688.e2. PubMed ID: 30257286
[TBL] [Abstract][Full Text] [Related]
23. Accuracy of the IASLC/ATS/ERS histological subtyping of stage I lung adenocarcinoma on intraoperative frozen sections.
Trejo Bittar HE; Incharoen P; Althouse AD; Dacic S
Mod Pathol; 2015 Aug; 28(8):1058-63. PubMed ID: 26022456
[TBL] [Abstract][Full Text] [Related]
24. Feasibility of intraoperative diagnosis of lung adenocarcinoma in situ to avoid excessive resection.
Shima T; Kinoshita T; Sasaki N; Uematsu M; Sugita Y; Shimizu R; Harada M; Hishima T; Yamamoto A; Horio H
J Thorac Dis; 2021 Mar; 13(3):1338-1346. PubMed ID: 33841927
[TBL] [Abstract][Full Text] [Related]
25. A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size.
Suzuki S; Sakurai H; Masai K; Asakura K; Nakagawa K; Motoi N; Watanabe SI
Ann Thorac Surg; 2017 Sep; 104(3):1027-1032. PubMed ID: 28551046
[TBL] [Abstract][Full Text] [Related]
26. Predictors of upstage and treatment strategies for stage IA lung cancers after sublobar resection for adenocarcinoma in situ and minimally invasive adenocarcinoma.
Su H; Gu C; She Y; Xu L; Yang P; Xie H; Zhao S; Wu C; Xie D; Chen C
Transl Lung Cancer Res; 2021 Jan; 10(1):32-44. PubMed ID: 33569291
[TBL] [Abstract][Full Text] [Related]
27. The Effect of Resection Margin Distance and Invasive Component Size on Recurrence After Sublobar Resection in Patients With Small (≤2 Cm) Lung Adenocarcinoma.
Moon Y; Park JK; Lee KY
World J Surg; 2020 Mar; 44(3):990-997. PubMed ID: 31712844
[TBL] [Abstract][Full Text] [Related]
28. Tumor histology predicts mediastinal nodal status and may be used to guide limited lymphadenectomy in patients with clinical stage I non-small cell lung cancer.
Cheng X; Zheng D; Li Y; Li H; Sun Y; Xiang J; Chen H
J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2648-2656.e2. PubMed ID: 29548592
[TBL] [Abstract][Full Text] [Related]
29. Comparison between CT tumor size and pathological tumor size in frozen section examinations of lung adenocarcinoma.
Isaka T; Yokose T; Ito H; Imamura N; Watanabe M; Imai K; Nishii T; Woo T; Yamada K; Nakayama H; Masuda M
Lung Cancer; 2014 Jul; 85(1):40-6. PubMed ID: 24751107
[TBL] [Abstract][Full Text] [Related]
30. Predictors of Invasiveness in Adenocarcinoma of Lung with Lepidic Growth Pattern.
Young TJ; Salehi-Rad R; Ronaghi R; Yanagawa J; Shahrouki P; Villegas BE; Cone B; Fishbein GA; Wallace WD; Abtin F; Barjaktarevic I
Med Sci (Basel); 2022 Jun; 10(3):. PubMed ID: 35893116
[TBL] [Abstract][Full Text] [Related]
31. Comparison of outcomes following lobectomy, segmentectomy, and wedge resection based on pathological subtyping in patients with pN0 invasive lung adenocarcinoma ≤1 cm.
Song W; Hou Y; Zhang J; Zhou Q
Cancer Med; 2022 Dec; 11(24):4784-4795. PubMed ID: 35570370
[TBL] [Abstract][Full Text] [Related]
32. Computed tomography density is not associated with pathological tumor invasion for pure ground-glass nodules.
Fu F; Zhang Y; Wang S; Li Y; Wang Z; Hu H; Chen H
J Thorac Cardiovasc Surg; 2021 Aug; 162(2):451-459.e3. PubMed ID: 32711984
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of patients with different lepidic percentage and tumor size of stage I lung adenocarcinoma.
Liu C; Wang LC; Chen HS; Yeh YC; Hsu PK; Huang CS; Hsieh CC; Hsu HS
Thorac Cancer; 2022 Jul; 13(14):2005-2013. PubMed ID: 35680127
[TBL] [Abstract][Full Text] [Related]
34. Impact of histological components on selecting limited lymphadenectomy for lung adenocarcinoma ≤ 2 cm.
Sun W; Su H; Liu J; Zhang L; Li M; Xie H; Xu L; Zhao S; She Y; Tang H; Wu C; Ke H; Chen C;
Lung Cancer; 2020 Dec; 150():36-43. PubMed ID: 33059150
[TBL] [Abstract][Full Text] [Related]
35. Lung Adenocarcinoma Invasiveness Risk in Pure Ground-Glass Opacity Lung Nodules Smaller than 2 cm.
Lee GD; Park CH; Park HS; Byun MK; Lee IJ; Kim TH; Lee S
Thorac Cardiovasc Surg; 2019 Jun; 67(4):321-328. PubMed ID: 29359309
[TBL] [Abstract][Full Text] [Related]
36. Comparison of malignant grade between pure and partially invasive types of early lung adenocarcinoma.
Sasada S; Nakayama H; Miyata Y; Tsubokawa N; Mimae T; Yoshiya T; Murakami S; Ito H; Okada M
Ann Thorac Surg; 2015 Mar; 99(3):956-60. PubMed ID: 25620597
[TBL] [Abstract][Full Text] [Related]
37. A simple prediction model using size measures for discrimination of invasive adenocarcinomas among incidental pulmonary subsolid nodules considered for resection.
Kim H; Goo JM; Park CM
Eur Radiol; 2019 Apr; 29(4):1674-1683. PubMed ID: 30255253
[TBL] [Abstract][Full Text] [Related]
38. Nomogram for Predicting the Risk of Invasive Pulmonary Adenocarcinoma for Pure Ground-Glass Nodules.
Wang L; Shen W; Xi Y; Liu S; Zheng D; Jin C
Ann Thorac Surg; 2018 Apr; 105(4):1058-1064. PubMed ID: 29452996
[TBL] [Abstract][Full Text] [Related]
39. Challenges for real-time intraoperative diagnosis of high risk histology in lung adenocarcinoma: A necessity for sublobar resection.
Takahashi Y; Kuroda H; Oya Y; Matsutani N; Matsushita H; Kawamura M
Thorac Cancer; 2019 Aug; 10(8):1663-1668. PubMed ID: 31287246
[TBL] [Abstract][Full Text] [Related]
40. Outcomes and predictive factors for pathological node-positive in radiographically pure-solid, small-sized lung adenocarcinoma.
Kayata H; Isaka M; Terada Y; Mizuno K; Yasuura Y; Kojima H; Ohde Y
Gen Thorac Cardiovasc Surg; 2019 Jun; 67(6):544-550. PubMed ID: 30627979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
